Migraine: CGRP-targeting antibodies reduce migraine frequency
- PMID: 29242523
- DOI: 10.1038/nrneurol.2017.177
Migraine: CGRP-targeting antibodies reduce migraine frequency
Comment on
-
Fremanezumab for the Preventive Treatment of Chronic Migraine.N Engl J Med. 2017 Nov 30;377(22):2113-2122. doi: 10.1056/NEJMoa1709038. N Engl J Med. 2017. PMID: 29171818 Clinical Trial.
-
A Controlled Trial of Erenumab for Episodic Migraine.N Engl J Med. 2017 Nov 30;377(22):2123-2132. doi: 10.1056/NEJMoa1705848. N Engl J Med. 2017. PMID: 29171821 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
